Total Payments
$927.43
2020 Payments
$19.60
Companies
7
Transactions
35
Medicare Patients
578
Medicare Billing
$66,807
Payment Breakdown by Category
Food & Beverage$727.53 (78.4%)
Education$199.90 (21.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $727.53 | 33 | 78.4% |
| Education | $199.90 | 2 | 21.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $307.26 | 16 | $0 (2020) |
| Gilead Sciences, Inc. | $266.62 | 7 | $0 (2019) |
| Janssen Products, LP | $199.90 | 2 | $0 (2017) |
| Janssen Biotech, Inc. | $109.15 | 7 | $0 (2019) |
| Theratechnologies Inc. | $18.58 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $15.13 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $10.79 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $19.60 | 1 | ViiV Healthcare Company ($19.60) |
| 2019 | $148.70 | 8 | Janssen Biotech, Inc. ($62.87) |
| 2018 | $375.91 | 15 | Gilead Sciences, Inc. ($202.34) |
| 2017 | $383.22 | 11 | Janssen Products, LP ($199.90) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/24/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: HIV | ||||||
| 07/31/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/28/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.71 | General |
| 03/14/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/06/2019 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: HIV | ||||||
| 02/20/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/06/2019 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: HIV | ||||||
| 01/17/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/09/2019 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: HIV | ||||||
| 12/20/2018 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/02/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 11/02/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DELSTRIGO | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/10/2018 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: HIV | ||||||
| 10/05/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $125.98 | General |
| 10/03/2018 | Janssen Scientific Affairs, LLC | Symtuza (Drug), PREZISTA, PREZCOBIX | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/20/2018 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/20/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.82 | General |
| 08/01/2018 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/18/2018 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: HIV | ||||||
| 06/07/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: HIV | ||||||
| 04/18/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: HIV | ||||||
| 04/02/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.29 | General |
| 03/14/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: HIV | ||||||
| 02/22/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: HIV | ||||||
| 11/27/2017 | Janssen Products, LP | PREZCOBIX (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 7 | 227 | 369 | $64,790 | $26,076 |
| 2020 | 9 | 351 | 647 | $102,035 | $40,732 |
Total Patients
578
Total Services
1,016
Medicare Billing
$66,807
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 61 | 137 | $19,180 | $7,700 | 40.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 45 | $12,600 | $5,631 | 44.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 46 | $9,660 | $3,701 | 38.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 40 | $8,200 | $3,135 | 38.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 39 | 73 | $5,840 | $2,242 | 38.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 14 | $5,530 | $2,145 | 38.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $3,780 | $1,523 | 40.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 87 | 237 | $33,180 | $13,941 | 42.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 127 | $26,670 | $8,810 | 33.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 66 | 132 | $10,560 | $4,217 | 39.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 39 | $7,995 | $3,307 | 41.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 18 | $7,110 | $2,962 | 41.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 24 | $6,480 | $2,688 | 41.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 31 | 40 | $3,600 | $2,358 | 65.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 16 | $4,480 | $1,676 | 37.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 14 | $1,960 | $772.49 | 39.4% |
About Dr. Patrick Haggerty, MD
Dr. Patrick Haggerty, MD is a Infectious Disease healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184691552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Haggerty, MD has received a total of $927.43 in payments from pharmaceutical and medical device companies, with $19.60 received in 2020. These payments were reported across 35 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($727.53).
As a Medicare-enrolled provider, Haggerty has provided services to 578 Medicare beneficiaries, totaling 1,016 services with total Medicare billing of $66,807. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Norfolk, VA
- Active Since 03/03/2006
- Last Updated 02/09/2017
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1184691552
Products in Payments
- TRIUMEQ (Drug) $226.29
- PREZCOBIX (Drug) $199.90
- Symtuza (Drug) $124.28
- JULUCA (Drug) $61.37
- DOVATO (Drug) $19.60
- EGRIFTA (Drug) $18.58
- ISENTRESS (Drug) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Norfolk
Dr. Edward Oldfield, Md, MD
Infectious Disease — Payments: $22,590
Infectious Disease $22,590
Moumita Sarker, Md, MD
Infectious Disease — Payments: $4,449
Infectious Disease $4,449
Afua Ntem-Mensah, M.d, M.D
Infectious Disease — Payments: $1,823
Infectious Disease $1,823
Dr. Catherine Derber, M.d, M.D
Infectious Disease — Payments: $762.52
Infectious Disease $762.52
James Radike, M.d, M.D
Infectious Disease — Payments: $747.15
Infectious Disease $747.15
Donice Libby, D.o, D.O
Infectious Disease — Payments: $557.88
Infectious Disease $557.88